Protect Personal Importation
Support current patient access to safe, lower-cost medicines from reliable foreign sources
Maximize access to safe and affordable imported drugs through executive authority and legislative reform.
Brand-name drugs cost about 75% less in other high-income countries. That disparity is unjust. Pharmaceutical companies argue that drugs from other countries are dangerous. That claim is overstated. Identical or equally safe and effective versions of FDA-approved drugs are widely used in peer countries.
Permitting personal prescription drug importation in the near term, and enabling commercial-scale importation beyond Canada over time, will move the United States toward price parity with its allied trading partners.
Support current patient access to safe, lower-cost medicines from reliable foreign sources
Support executive action under 804(j)(2) to expressly permit safe personal importation through waivers
Support federal legislation to allow wholesale drug importation beyond Canada
Showcase one current piece with cleaner formatting and a more serious editorial presentation.
Read more →Preserve recent content while presenting it as supporting material rather than the page lead.
Read more →Use three strong content cards rather than a cluttered feed to keep the page readable.
Read more →Subscribe for updates on drug pricing, safe importation, public policy, and major developments affecting access to affordable medicines.